Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Retirees benefit from selecting tax-efficient asset classes and optimized withdrawal sequencing. Learn which classes to favor and why.
23,930 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
As memory prices surge in 2026, Corsair Gaming emerges as the leading beneficiary with improved margins, a new buybac...
Biodesix faces a pivotal year in 2025. This guide breaks down the factors shaping biodesix (bdsx) 2025 earnings, the ...
D-Wave Quantum stock gained momentum this week as investors weighed upcoming results and potential partnerships. This...
A weekend strike campaign put the U.S. on center stage as China and Russia offered only verbal condemnations. Markets...
2025 marked a turning point as hardship withdrawals from 401(K) plans hit a new high, signaling mounting financial st...
When a top executive sells a large block of shares, investors want clarity. This guide breaks down what RingCentral's...
The NANC ETF, built to mirror congressional disclosure trades, is facing a tougher 2026 as interest rates move higher...
Playnance confirms G Coin launch ahead of its March 18 Token Generation Event, underscoring a live ecosystem with hun...
Ripple's latest private-market move values the company at $50 billion and signals confidence in its ecosystem, even a...
Goldman Sachs has quietly built a $154 million stake in spot XRP ETFs, making it the largest disclosed holder as XRP ...
A missile strike on Qatar’s LNG facilities pushes oil and gas markets higher. Traders point to wall street buying the...